RxDoctor Payments Data

John Ohman, MD

Vascular Surgery · Saint Louis, MONPI 1093078115

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Bolton Medical Inc at 33.3% of the total. Reporting peaked in 2024 at $50,614 and has fallen 54.8% since, to $22,858 in 2025. Among vascular surgery clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$112,582in general payments, 2019–2025

Across 263 payments — averaging $428.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bolton Medical Inc$38K
  • W. L. Gore & Associates, Inc.$27K
  • Globus Medical$27K
  • Cook Incorporated$10K
  • Penumbra, Inc.$3K
  • Cook Medical LLC$3K
  • plus $5K from 14 others
$55,204in research payments, 2019–2025

Across 17 payments — averaging $3247.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bolton Medical Inc$51K
  • W. L. Gore & Associates, Inc.$4K

What the payments were for

  • Consulting fees$63,41856%
  • Speaking & faculty fees$19,05017%
  • Travel & lodging$17,86816%
  • Food & beverage$11,24710%
  • Education$1,0001%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$112,582 in reported general payments places this provider in the 90th percentile of 92 vascular surgery providers in Missouri.

See all vascular surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$167,505
Medicare patients
224
Services billed
428

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban18$10,060
EliquisApixaban11$6,456
ClopidogrelClopidogrel Bisulfate58$238
Gabapentin11$150
Prednisone15$13
Atorvastatin Calcium12$9

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →